SAYSD1
SAYSvFN domain-containing protein 1
Also known as: C6orf64, FLJ11101, SAYS1_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9NPB0
- Gene
- SAYSD1
- Ensembl
- ENSG00000112167
- Chromosome
- 6
- Canonical length
- 183 aa
- Protein class
- Predicted membrane proteins
- Subcellular location
- Vesicles
OverviewNCBI Gene
Enables UFM1-modified protein reader activity. Involved in protein quality control for misfolded or incompletely synthesized proteins and rescue of stalled ribosome. Located in intracellular membrane-bounded organelle. Is active in endoplasmic reticulum. [provided by Alliance of Genome Resources, Apr 2025]
Canonical amino-acid sequenceUniProt
183 residues, UniProt reviewed canonical sequence.
>Q9NPB0|SAYSD1
1 MEQRLAEFRA ARKRAGLAAQ PPAASQGAQT PGEKAEAAAT LKAAPGWLKR FLVWKPRPAS
61 ARAQPGLVQE AAQPQGSTSE TPWNTAIPLP SCWDQSFLTN ITFLKVLLWL VLLGLFVELE
121 FGLAYFVLSL FYWMYVGTRG PEEKKEGEKS AYSVFNPGCE AIQGTLTAEQ LERELQLRPL
181 AGRLocalizationUniProt · AlphaFold · HPA
Whether an antibody against SAYSD1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.62
- Highest tissue expression
- 31 nTPM
Expression across tissuesHPA
Tissue
- testis: 31 nTPM
- salivary gland: 7.9 nTPM
- liver: 6.8 nTPM
- epididymis: 6.6 nTPM
- thymus: 6.6 nTPM
- pancreas: 6.2 nTPM
Single-cell type
- late primary spermatocytes: 428 nCPM
- early spermatids: 109 nCPM
- early primary spermatocytes: 86 nCPM
- late spermatids: 80 nCPM
- oocytes: 69 nCPM
- parietal cells: 44 nCPM
Immune cell
- eosinophil: 23 nTPM
- T-reg: 20 nTPM
- naive CD4 T-cell: 18 nTPM
- naive B-cell: 18 nTPM
- naive CD8 T-cell: 16 nTPM
- memory B-cell: 16 nTPM
Brain region
- white matter: 8.7 nTPM
- choroid plexus: 8.5 nTPM
- midbrain: 7.1 nTPM
- spinal cord: 7.1 nTPM
- basal ganglia: 7 nTPM
- medulla oblongata: 7 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.65
- gnomAD pLI
- 0
- gnomAD missense Z
- -0.53
- DepMap mean gene effect
- -0.12
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 8% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- protein quality control for misfolded or incompletely synthesized proteins
- rescue of stalled ribosome
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- SAYSvFN domain
- SAYSvFN domain-containing protein 1
- Uncharacterized conserved domain (SAYSvFN)
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads SAYSD1 as an antibody target. Whether an autoantibody or antibody against SAYSD1 could matter depends on whether native SAYSD1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
SAYSD1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label SAYSD1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...